Ken Akao
Toyoake, 4701192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BRAF V600E-mutant squamous cell carcinoma of the lung in patients with a history of papillary thyroid carcinoma: A three-case series.
Journal: Respiratory investigation
Published: May 29, 2025
TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.
Journal: Molecular cancer therapeutics
Published: May 01, 2024
It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC.
Journal: Exploration of targeted anti-tumor therapy
Published: December 05, 2023
Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.
Journal: Cancer cell international
Published: July 12, 2021
Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation.
Journal: Molecular cancer research : MCR
Published: July 19, 2020
Flow cytometric analysis of lymphocyte profiles in mediastinal lymphadenopathy of sarcoidosis.
Journal: PloS one
Published: June 08, 2018
Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.
Journal: BMC pulmonary medicine
Published: August 02, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026